{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T14:39:05Z","timestamp":1778683145099,"version":"3.51.4"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,14]],"date-time":"2020-10-14T00:00:00Z","timestamp":1602633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,14]],"date-time":"2020-10-14T00:00:00Z","timestamp":1602633600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST 106-2314-B-006-025"],"award-info":[{"award-number":["MOST 106-2314-B-006-025"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010613","name":"Taipei Medical University Hospital","doi-asserted-by":"publisher","award":["109TMU-TMUH-03"],"award-info":[{"award-number":["109TMU-TMUH-03"]}],"id":[{"id":"10.13039\/501100010613","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The epidemiology of diabetes and idiopathic cardiomyopathy have limited data. We investigated the overall and the age-, sex-, and urbanization-specific incidence and relative hazard of idiopathic cardiomyopathy in association with type 2 diabetes and various anti-diabetic medications used in Taiwan.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 474,268 patients with type 2 diabetes were identified from ambulatory care and inpatient claims in 2007\u20132009 from Taiwan\u2019s National Health Insurance (NHI) database. We randomly selected 474,266 age-, sex-, and diagnosis date-matched controls from the registry of NHI beneficiaries. All study subjects were linked to ambulatory care and inpatient claims (up to the end of 2016) to identify the possible diagnosis of idiopathic cardiomyopathy. The person-year approach with Poisson assumption was used to estimate the incidence, and Cox proportional hazard regression model with Fine and Gray\u2019s method was used to estimate the relative hazards of idiopathic cardiomyopathy in relation to type 2 diabetes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The overall incidence of idiopathic cardiomyopathy for men and women patients, respectively, was 3.83 and 2.94 per 10,000 person-years, which were higher than the corresponding men and women controls (2.00 and 1.34 per 10,000 person-years). Compared with the control group, patients with type 2 diabetes were significantly associated with an increased hazard of idiopathic cardiomyopathy (adjusted hazard ratio [aHR]: 1.60, 95% confidence interval [CI]: 1.45\u20131.77] in all age and sex stratifications except in those men aged\u2009&gt;\u200964\u00a0years. Patients with type 2 diabetes aged\u2009&lt;\u200945\u00a0years confronted the greatest increase in the hazard of idiopathic cardiomyopathy, with an aHR of 3.35 (95% CI 2.21\u20135.06) and 3.48 (95% CI 1.60\u20137.56) for men and women, respectively. The usage of some anti-diabetic medications revealed lower risks of idiopathic cardiomyopathy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In Taiwan, diabetes increased the risk of idiopathic cardiomyopathy in both sexes and in all age groups, except in men aged\u2009&gt;\u200964\u00a0years. Younger patients were vulnerable to have higher HRs of idiopathic cardiomyopathy. Some anti-diabetic medications may reduce the risks of cardiomyopathy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12933-020-01144-y","type":"journal-article","created":{"date-parts":[[2020,10,14]],"date-time":"2020-10-14T09:02:45Z","timestamp":1602666165000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Incidence of idiopathic cardiomyopathy in patients with type 2 diabetes in Taiwan: age, sex, and urbanization status-stratified analysis"],"prefix":"10.1186","volume":"19","author":[{"given":"Hua-Fen","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya-Hui","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsien-Jung","family":"Lo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9010-0045","authenticated-orcid":false,"given":"Muhammad Atoillah","family":"Isfandiari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santi","family":"Martini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4376-6298","authenticated-orcid":false,"given":"Wen-Hsuan","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0321-8908","authenticated-orcid":false,"given":"Chung-Yi","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,10,14]]},"reference":[{"issue":"3","key":"1144_CR1","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1111\/j.1464-5491.2004.01116.x","volume":"21","author":"SH Song","year":"2004","unstructured":"Song SH, Brown PM. Coronary heart disease risk assessment in diabetes mellitus: comparison of UKPDS risk engine with Framingham risk assessment function and its clinical implications. Diabet Med. 2004;21(3):238\u201345.","journal-title":"Diabet Med"},{"issue":"6","key":"1144_CR2","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/0002-9149(72)90595-4","volume":"30","author":"S Rubler","year":"1972","unstructured":"Rubler S, Dlugash J, Yuceoglu YZ, Kumral T, Branwood AW, Grishman A. New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol. 1972;30(6):595\u2013602.","journal-title":"Am J Cardiol"},{"issue":"3","key":"1144_CR3","doi-asserted-by":"publisher","first-page":"404","DOI":"10.3904\/kjim.2016.208","volume":"32","author":"WS Lee","year":"2017","unstructured":"Lee WS, Kim J. Diabetic cardiomyopathy: where we are and where we are going. Korean J Intern Med. 2017;32(3):404\u201321.","journal-title":"Korean J Intern Med"},{"issue":"1","key":"1144_CR4","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/1047-2797(94)90044-2","volume":"4","author":"SS Coughlin","year":"1994","unstructured":"Coughlin SS, Pearle DL, Baughman KL, Wasserman A, Tefft MC. Diabetes mellitus and risk of idiopathic dilated cardiomyopathy* The Washington. DC Dilated Cardiomyopathy Study Ann Epidemiol. 1994;4(1):67\u201374.","journal-title":"DC Dilated Cardiomyopathy Study Ann Epidemiol"},{"issue":"10","key":"1144_CR5","doi-asserted-by":"publisher","first-page":"2791","DOI":"10.2337\/diacare.26.10.2791","volume":"26","author":"AG Bertoni","year":"2003","unstructured":"Bertoni AG, Tsai A, Kasper EK, Brancati FL. Diabetes and idiopathic cardiomyopathy: a nationwide case-control study. Diabetes Care. 2003;26(10):2791\u20135.","journal-title":"Diabetes Care"},{"issue":"5","key":"1144_CR6","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.cardfail.2014.02.007","volume":"20","author":"S Dandamudi","year":"2014","unstructured":"Dandamudi S, Slusser J, Mahoney DW, Redfield MM, Rodeheffer RJ, Chen HH. The prevalence of diabetic cardiomyopathy: a population-based study in Olmsted County. Minnesota J Card Fail. 2014;20(5):304\u20139.","journal-title":"Minnesota J Card Fail"},{"issue":"1","key":"1144_CR7","doi-asserted-by":"publisher","first-page":"75","DOI":"10.2337\/dc07-1072","volume":"31","author":"HF Chen","year":"2008","unstructured":"Chen HF, Ho CA, Li CY. Increased risks of hip fracture in diabetic patients of Taiwan: a population-based study. Diabetes Care. 2008;31(1):75\u201380.","journal-title":"Diabetes Care"},{"issue":"3","key":"1144_CR8","first-page":"77","volume":"22","author":"JFR Lu","year":"2003","unstructured":"Lu JFR, Hsiao WC. Does Universal health insurance make health care unaffordable? Lessons from Taiwan Health Aff. 2003;22(3):77\u201388.","journal-title":"Lessons from Taiwan Health Aff"},{"issue":"3","key":"1144_CR9","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/S0168-8510(96)00877-9","volume":"39","author":"TL Chiang","year":"1997","unstructured":"Chiang TL. Taiwan\u2019s 1995 healthcare reform. Health Policy. 1997;39(3):225\u201339.","journal-title":"Health Policy"},{"key":"1144_CR10","unstructured":"National Health Insurance Administration Website. 2012. https:\/\/www.nhi.gov.tw\/Content_List.aspx?n=C3C59864C82A96C6&topn=5FE8C9FEAE863B46. Assessed 11 Oct 2019."},{"issue":"1","key":"1144_CR11","first-page":"1","volume":"4","author":"CY Liu","year":"2006","unstructured":"Liu CY, Hung YT, Chuang YL, Chen YJ, Weng WS, Liu JS, Liang KY. Incorporating development stratification of Taiwan townships into sampling design of large scale health interview survey. J Health Manag (in Chinese). 2006;4(1):1\u201322.","journal-title":"J Health Manag (in Chinese)"},{"issue":"1","key":"1144_CR12","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12933-017-0506-x","volume":"16","author":"A Lorenzo-Almor\u00f3s","year":"2017","unstructured":"Lorenzo-Almor\u00f3s A, Tu\u00f1\u00f3n J, Orejas M, Cort\u00e9s M, Egido J, Lorenzo \u00d3. Diagnostic approaches for diabetic cardiomyopathy. Cardiovasc Diabetol. 2017;16(1):28.","journal-title":"Cardiovasc Diabetol"},{"issue":"4","key":"1144_CR13","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1111\/j.1748-0361.2005.tb00110.x","volume":"21","author":"HF Tan","year":"2005","unstructured":"Tan HF, Tseng HF, Chang CK, Lin W, Hsiao SH. Accessibility assessment of the Health Care Improvement Program in rural Taiwan. J Rural Health. 2005;21(4):372\u20137.","journal-title":"J Rural Health"},{"issue":"3","key":"1144_CR14","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1161\/01.CIR.80.3.564","volume":"80","author":"MB Codd","year":"1989","unstructured":"Codd MB, Sugrue DD, Gersh BJ, Melton LJ 3rd. Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy. A population-based study in Olmsted County, Minnesota, 1975\u20131984. Circulation. 1989;80(3):564\u201372.","journal-title":"Circulation"},{"issue":"3","key":"1144_CR15","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1136\/hrt.52.3.327","volume":"52","author":"JP Bagger","year":"1984","unstructured":"Bagger JP, Baandrup U, Rasmussen K, M\u00f8ller M, Vesterlund T. Cardiomyopathy in western Denmark. Br Heart J. 1984;52(3):327\u201331.","journal-title":"Br Heart J"},{"issue":"1","key":"1144_CR16","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1159\/000089387","volume":"15","author":"AA El-Menyar","year":"2006","unstructured":"El-Menyar AA, Bener A, Numan MT, Morcos S, Taha RY, Al-Suwaidi J. Epidemiology of idiopathic cardiomyopathy in Qatar during 1996\u20132003. Med Princ Pract. 2006;15(1):56\u201361.","journal-title":"Med Princ Pract"},{"issue":"3","key":"1144_CR17","doi-asserted-by":"publisher","first-page":"588","DOI":"10.2337\/diacare.29.03.06.dc05-1501","volume":"29","author":"AG Bertoni","year":"2006","unstructured":"Bertoni AG, Goff DC Jr, D'Agostino RB Jr, Liu K, Hundley WG, Lima JA, Polak JF, Saad MF, Szklo M, Tracy RP, Siscovik DS. Diabetic cardiomyopathy and subclinical cardiovascular disease: the Multi-Ethnic Study of Atherosclerosis (MESA). Diabetes Care. 2006;29(3):588\u201394.","journal-title":"Diabetes Care"},{"issue":"1","key":"1144_CR18","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s12933-019-0940-z","volume":"18","author":"EHM Paiman","year":"2019","unstructured":"Paiman EHM, van Eyk HJ, Bizino MB, Dekkers IA, de Heer P, Smit JWA, Jazet IM, Lamb HJ. Phenotyping diabetic cardiomyopathy in Europeans and South Asians. Cardiovasc Diabetol. 2019;18(1):133.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"1144_CR19","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.cpcardiol.2012.07.003","volume":"38","author":"D Fairweather","year":"2013","unstructured":"Fairweather D, Cooper LT Jr, Blauwet LA. Sex and gender differences in myocarditis and dilated cardiomyopathy. Curr Probl Cardiol. 2013;38(1):7\u201346.","journal-title":"Curr Probl Cardiol"},{"issue":"24","key":"1144_CR20","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1001\/jama.2019.19365","volume":"322","author":"YJ Cheng","year":"2019","unstructured":"Cheng YJ, Kanaya AM, Araneta MRG, Saydah SH, Kahn HS, Gregg EW, Fujimoto WY, Imperatore G. Prevalence of diabetes by race and ethnicity in the United States, 2011\u20132016. JAMA. 2019;322(24):2389\u201398.","journal-title":"JAMA"},{"issue":"9","key":"1144_CR21","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1093\/oxfordjournals.aje.a008831","volume":"143","author":"SS Coughlin","year":"1996","unstructured":"Coughlin SS, Tefft MC, Rice JC, Gerone JL, Baughman KL. Epidemiology of idiopathic dilated cardiomyopathy in the elderly: pooled results from two case-control studies. Am J Epidemiol. 1996;143(9):881\u20138.","journal-title":"Am J Epidemiol"},{"issue":"5","key":"1144_CR22","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1089\/jwh.2008.0918","volume":"18","author":"HF Chen","year":"2009","unstructured":"Chen HF, Lee SP, Li CY. Sex differences in the incidence of hemorrhagic and ischemic stroke among diabetics in Taiwan. J Womens Health. 2009;18(5):647\u201354.","journal-title":"J Womens Health"},{"issue":"1","key":"1144_CR23","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1111\/dom.13493","volume":"21","author":"HF Chen","year":"2019","unstructured":"Chen HF, Ho CA, Li CY. Risk of heart failure in a population with type 2 diabetes versus a population without diabetes with and without coronary heart disease. Diabetes Obes Metab. 2019;21(1):112\u20139.","journal-title":"Diabetes Obes Metab"},{"issue":"10","key":"1144_CR24","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1007\/s00125-019-4939-5","volume":"62","author":"AG Huebschmann","year":"2019","unstructured":"Huebschmann AG, Huxley RR, Kohrt WM, Zeitler P, Regensteiner JG, Reusch JEB. Sex differences in the burden of type 2 diabetes and cardiovascular risk across the life course. Diabetologia. 2019;62(10):1761\u201372.","journal-title":"Diabetologia"},{"issue":"2","key":"1144_CR25","doi-asserted-by":"publisher","first-page":"354","DOI":"10.2337\/dc06-1772","volume":"30","author":"RP Donahue","year":"2007","unstructured":"Donahue RP, Rejman K, Rafalson LB, Dmochowski J, Stranges S, Trevisan M. Sex differences in endothelial function markers before conversion to pre-diabetes: does the clock start ticking earlier among women? The Western New York Study. Diabetes Care. 2007;30(2):354\u20139.","journal-title":"Diabetes Care"},{"issue":"3","key":"1144_CR26","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1210\/er.2015-1137","volume":"37","author":"A Kautzky-Willer","year":"2016","unstructured":"Kautzky-Willer A, Harreiter J, Pacini G. Sex and gender differences in risk, pathophysiology and complications of type 2 diabetes mellitus. Endocr Rev. 2016;37(3):278\u2013316.","journal-title":"Endocr Rev"},{"issue":"24","key":"1144_CR27","doi-asserted-by":"publisher","first-page":"2742","DOI":"10.1161\/CIRCULATIONAHA.118.039100","volume":"139","author":"AK Wright","year":"2019","unstructured":"Wright AK, Kontopantelis E, Emsley R, Buchan I, Mamas MA, Sattar N, Ashcroft DM, Rutter MK. Cardiovascular risk and risk factor management in type 2 diabetes mellitus. Circulation. 2019;139(24):2742\u201353.","journal-title":"Circulation"},{"issue":"7","key":"1144_CR28","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1056\/NEJMsa032214","volume":"353","author":"V Vaccarino","year":"2005","unstructured":"Vaccarino V, Rathore SS, Wenger NK, Frederick PD, Abramson JL, Barron HV, Manhapra A, Mallik S, Krumholz HM. Sex and racial differences in the management of acute myocardial infarction, 1994 through 2002. N Engl J Med. 2005;353(7):671\u201382.","journal-title":"N Engl J Med."},{"issue":"12","key":"1144_CR29","doi-asserted-by":"publisher","first-page":"5967","DOI":"10.1210\/en.2006-0728","volume":"147","author":"M Aragno","year":"2006","unstructured":"Aragno M, Mastrocola R, Medana C, Catalano MG, Vercellinatto I, Danni O, Boccuzzi G. Oxidative stress-dependent impairment of cardiac-specific transcription factors in experimental diabetes. Endocrinology. 2006;147(12):5967\u201374.","journal-title":"Endocrinology"},{"issue":"1","key":"1144_CR30","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s00395-018-0711-0","volume":"114","author":"C Riehle","year":"2018","unstructured":"Riehle C, Bauersachs J. Of mice and men: models and mechanisms of diabetic cardiomyopathy. Basic Res Cardiol. 2018;114(1):2.","journal-title":"Basic Res Cardiol"},{"issue":"3","key":"1144_CR31","doi-asserted-by":"publisher","first-page":"749","DOI":"10.2337\/dc10-1681","volume":"34","author":"MJ Blaha","year":"2011","unstructured":"Blaha MJ, DeFilippis AP, Rivera JJ, Budoff MJ, Blankstein R, Agatston A, Szklo M, Lakoski SG, Bertoni AG, Kronmal RA, Blumenthal RS, Nasir K. The relationship between insulin resistance and incidence and progression of coronary artery calcification: the Multi-Ethnic Study of Atherosclerosis (MESA). Diabetes Care. 2011;34(3):749\u201351.","journal-title":"Diabetes Care"},{"issue":"1","key":"1144_CR32","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12933-018-0684-1","volume":"17","author":"N Ghosh","year":"2018","unstructured":"Ghosh N, Katare R. Molecular mechanism of diabetic cardiomyopathy and modulation of microRNA function by synthetic oligonucleotides. Cardiovasc Diabetol. 2018;17(1):43.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"1144_CR33","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s12933-019-0865-6","volume":"18","author":"M Kozakova","year":"2019","unstructured":"Kozakova M, Morizzo C, Goncalves I, Natali A, Nilsson J, Palombo C. Cardiovascular organ damage in type 2 diabetes mellitus: the role of lipids and inflammation. Cardiovasc Diabetol. 2019;18(1):61.","journal-title":"Cardiovasc Diabetol"},{"issue":"6","key":"1144_CR34","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1177\/1479164118794619","volume":"15","author":"I Johansson","year":"2018","unstructured":"Johansson I, Dahlstr\u00f6m U, Edner M, N\u00e4sman P, Ryd\u00e9n L, Norhammar A. Type 2 diabetes and heart failure: Characteristics and prognosis in preserved, mid-range and reduced ventricular function. Diab Vasc Dis Res. 2018;15(6):494\u2013503.","journal-title":"Diab Vasc Dis Res"},{"issue":"6","key":"1144_CR35","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.carpath.2015.08.001","volume":"24","author":"KE Gil","year":"2015","unstructured":"Gil KE, Pawlak A, Frontczak-Baniewicz M, Gil RJ, Nasierowska-Guttmejer A. The proposed new classification of coronary microcirculation as the predictor of the heart failure progression in idiopathic dilated cardiomyopathy. Cardiovasc Pathol. 2015;24(6):351\u20138.","journal-title":"Cardiovasc Pathol"},{"issue":"1","key":"1144_CR36","doi-asserted-by":"publisher","first-page":"e464","DOI":"10.1002\/hpm.2662","volume":"34","author":"BR Cheng","year":"2019","unstructured":"Cheng BR, Chang HT, Lin MH, Chen TJ, Chou LF, Hwang SJ. Rural-urban disparities in family physician practice patterns: a nationwide survey in Taiwan. Int J Health Plann Manage. 2019;34(1):e464\u201373.","journal-title":"Int J Health Plann Manage"},{"key":"1144_CR37","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.puhe.2017.06.009","volume":"151","author":"CC Chen","year":"2017","unstructured":"Chen CC, Chen LW, Cheng SH. Rural-urban differences in receiving guideline-recommended diabetes care and experiencing avoidable hospitalizations under a universal coverage health system: evidence from the past decade. Public Health. 2017;151:13\u201322.","journal-title":"Public Health"},{"issue":"1","key":"1144_CR38","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/s12889-020-8335-3","volume":"20","author":"CH Li","year":"2020","unstructured":"Li CH, Li CC, Lu CL, Wu JS, Ku LE, Li CY. Urban-rural disparity in lower extremities amputation in patients with diabetes after nearly two decades of universal health Insurance in Taiwan. BMC Public Health. 2020;20(1):212.","journal-title":"BMC Public Health"},{"issue":"9862","key":"1144_CR39","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/S0140-6736(12)60397-3","volume":"381","author":"BJ Maron","year":"2013","unstructured":"Maron BJ, Maron MS. Hypertrophic cardiomyopathy. Lancet. 2013;381(9862):242\u201355.","journal-title":"Lancet"},{"issue":"5","key":"1144_CR40","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1177\/1479164119843760","volume":"16","author":"SH Kim","year":"2019","unstructured":"Kim SH, Sung KC, Lee SK, et al. Longitudinal changes in left ventricular structure and function in patients with type 2 diabetes: normal weight versus overweight\/obesity. Diab Vasc Dis Res. 2019;16(5):450\u20137.","journal-title":"Diab Vasc Dis Res"},{"issue":"1","key":"1144_CR41","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1161\/CIRCRESAHA.118.311371","volume":"124","author":"HC Kenny","year":"2019","unstructured":"Kenny HC, Abel ED. Heart failure in type 2 diabetes mellitus: impact of glucose lowering agents, heart failure therapies and novel therapeutic strategies. Circ Res. 2019;124(1):121\u201341.","journal-title":"Circ Res"},{"issue":"1","key":"1144_CR42","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1161\/HYPERTENSIONAHA.117.09259","volume":"70","author":"T Tsujimoto","year":"2017","unstructured":"Tsujimoto T, Sugiyama T, Shapiro MF, Noda M, Kajio H. Risk of cardiovascular events in patients with diabetes mellitus on \u03b2-blockers. Hypertension. 2017;70(1):103\u201310.","journal-title":"Hypertension"},{"issue":"3","key":"1144_CR43","first-page":"244","volume":"35","author":"CC Wang","year":"2019","unstructured":"Wang CC, Wu CK, Tsai ML, Lee CM, Huang WC, Chou HH, Huang JL, Chi NH, Yen HW, Tzeng BH, Chang WT, Chang HY, Wang CH, Lu YY, Tsai JP, Su CH, Cherng WJ, Yin WH, Tsai CT, Wu YW, Lin JL, Hwang JJ. 2019 Focused Update of the guidelines of the taiwan society of cardiology for the diagnosis and treatment of heart failure. Acta Cardiol Sin. 2019;35(3):244\u201383.","journal-title":"Acta Cardiol Sin"},{"issue":"5","key":"1144_CR44","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1002\/ejhf.1161","volume":"20","author":"A Avogaro","year":"2018","unstructured":"Avogaro A, Fadini GP. Insulin treatment in patients with diabetes and heart failure: defendant on the stand. Eur J Heart Fail. 2018;20(5):896\u20137.","journal-title":"Eur J Heart Fail"},{"issue":"15","key":"1144_CR45","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","volume":"359","author":"RR Holman","year":"2008","unstructured":"Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008;359(15):1577\u201389.","journal-title":"N Engl J Med"},{"issue":"1","key":"1144_CR46","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S2213-8587(16)30316-3","volume":"5","author":"JM Gamble","year":"2017","unstructured":"Gamble JM, Chibrikov E, Twells LK, Midodzi WK, Young SW, MacDonald D, Majumdar SR. Association of insulin dosage with mortality or major adverse cardiovascular events: a retrospective cohort study. Lancet Diabetes Endocrinol. 2017;5(1):43\u201352.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1144_CR47","doi-asserted-by":"crossref","unstructured":"UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet. 1998;352(9131):854\u201365.","DOI":"10.1016\/S0140-6736(98)07037-8"},{"issue":"12","key":"1144_CR48","doi-asserted-by":"publisher","first-page":"2546","DOI":"10.1007\/s00125-010-1906-6","volume":"53","author":"C Andersson","year":"2010","unstructured":"Andersson C, Olesen JB, Hansen PR, Weeke P, Norgaard ML, J\u00f8rgensen CH, Lange T, Abildstr\u00f8m SZ, Schramm TK, Vaag A, K\u00f8ber L, Torp-Pedersen C, Gislason GH. Metformin treatment is associated with a low risk of mortality in diabetic patients with heart failure: a retrospective nationwide cohort study. Diabetologia. 2010;53(12):2546\u201353.","journal-title":"Diabetologia"},{"issue":"7","key":"1144_CR49","doi-asserted-by":"publisher","first-page":"e3173","DOI":"10.1002\/dmrr.3173","volume":"35","author":"AV Zilov","year":"2019","unstructured":"Zilov AV, Abdelaziz SI, AlShammary A, Zahrani AA, Amir A, Khalil SHA, Brand K, Elkafrawy N, Hassoun AAK, Jahed A, Jarrah N, Mrabeti S, Paruk I. Mechanisms of action of metformin with special reference to cardiovascular protection. Diabetes Metab Res Rev. 2019;35(7):e3173.","journal-title":"Diabetes Metab Res Rev"},{"issue":"11","key":"1144_CR50","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.2337\/dc07-0717","volume":"30","author":"E Erdmann","year":"2007","unstructured":"Erdmann E, Charbonnel B, Wilcox RG, Skene AM, Massi-Benedetti M, Yates J, Tan M, Spanheimer R, Standl E, Dormandy JA. Pioglitazone use and heart failure in patients with type 2 diabetes and preexisting cardiovascular disease: data from the PROactive study (PROactive 08). Diabetes Care. 2007;30(11):2773\u20138.","journal-title":"Diabetes Care"},{"issue":"9681","key":"1144_CR51","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1016\/S0140-6736(09)60953-3","volume":"373","author":"PD Home","year":"2009","unstructured":"Home PD, Pocock SJ, Beck-Nielsen H, Curtis PS, Gomis R, Hanefeld M, Jones NP, Komajda M, McMurray JJV. Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial. Lancet. 2009;373(9681):2125\u201335.","journal-title":"Lancet"},{"issue":"10","key":"1144_CR52","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1001\/jama.298.10.1180","volume":"298","author":"AM Lincoff","year":"2007","unstructured":"Lincoff AM, Wolski K, Nicholls SJ, Nissen SE. Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials. JAMA. 2007;298(10):1180\u20138.","journal-title":"JAMA"},{"issue":"4","key":"1144_CR53","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1038\/sj.bjp.0707452","volume":"153","author":"CE Quinn","year":"2008","unstructured":"Quinn CE, Hamilton PK, Lockhart CJ, McVeigh GE. Thiazolidinediones: effects on insulin resistance and the cardiovascular system. Br J Pharmacol. 2008;153(4):636\u201345.","journal-title":"Br J Pharmacol"},{"issue":"15","key":"1144_CR54","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1093\/eurheartj\/ehr077","volume":"32","author":"TK Schramm","year":"2011","unstructured":"Schramm TK, Gislason GH, Vaag A, Rasmussen JN, Folke F, Hansen ML, Fosb\u00f8l EL, K\u00f8lber L, Norgaard ML, Madsen M, Hanseb PR, Torp-Pedersen C. Mortality and cardiovascular risk associated with different insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous myocardial infarction: a nationwide study. Eur Heart J. 2011;32(15):1900\u20138.","journal-title":"Eur Heart J"},{"key":"1144_CR55","doi-asserted-by":"crossref","unstructured":"Scirica BM, Bhatt DL, Braunwald E, Steg PG, Davidson J, Hirshberg B, Ohman P, Frederich R, Wiviott SD, Hoffman EB, Cavender MA, Udell JA, Desai NR, Mosenzon O, McGuire DK, Ray KK, Leiter LA, Raz I, SAVOR-TIMI 53 Steering Committee and Investigators. Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus. N Engl J Med. 2013;369(14):1317\u201326.","DOI":"10.1056\/NEJMoa1307684"},{"issue":"9982","key":"1144_CR56","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1016\/S0140-6736(14)62225-X","volume":"385","author":"F Zannad","year":"2015","unstructured":"Zannad F, Cannon CP, Cushman WC, Bakris GL, Menon V, Perez AT, Fleck PR, Mehta CR, Kupfer S, Wilson C, Lam H, White WB. Heart failure and mortality outcomes in patients with type 2 diabetes taking alogliptin versus placebo in EXAMINE: a multicentre, randomised, double-blind trial. Lancet. 2015;385(9982):2067\u201376.","journal-title":"Lancet"},{"issue":"3","key":"1144_CR57","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1056\/NEJMoa1501352","volume":"373","author":"JB Green","year":"2015","unstructured":"Green JB, Bethel MA, Armstrong PW, Buse JB, Engel SS, Garg J, Josse R, Kaufman KD, Koglin J, Korn S, Lachin JM, McGuire DK, Pencina MJ, Standl E, Stein PP, Suryawanshi S, Van de Werf F, Peterson ED, Holman RR. Effect of sitagliptin on cardiovascular outcomes in type 2 diabetes. N Engl J Med. 2015;373(3):232\u201342.","journal-title":"N Engl J Med."},{"issue":"12","key":"1144_CR58","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1001\/jama.2019.13772","volume":"322","author":"J Rosenstock","year":"2019","unstructured":"Rosenstock J, Kahn SE, Johansen OE, et al. Effect of linagliptin vs glimepiride on major adverse cardiovascular outcomes in patients with type 2 diabetes: The CAROLINA Randomized Clinical Trial. JAMA. 2019;322(12):1155\u201366.","journal-title":"JAMA"},{"issue":"10","key":"1144_CR59","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1161\/CIRCRESAHA.117.311588","volume":"122","author":"AJ Scheen","year":"2018","unstructured":"Scheen AJ. Cardiovascular effects of new oral glucose-lowering agents: DPP-4 and SGLT-2 inhibitors. Circ Res. 2018;122(10):1439\u201359.","journal-title":"Circ Res"},{"key":"1144_CR60","doi-asserted-by":"crossref","unstructured":"Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JF, Nauck MA, Nissen SE, Pocock S, Poulter NR, Ravn LS, Steinberg WM, Stockner M, Zinman B, Bergenstal RM, Buse JB, LEADER Steering Committee, LEADER Trial Investigators. Liraglutide and cardiovascular outcomes in type 2 diabetes. N Engl J Med. 2016;375(4):311\u201322.","DOI":"10.1056\/NEJMoa1603827"},{"key":"1144_CR61","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1146\/annurev-med-042017-094221","volume":"70","author":"CK Kramer","year":"2019","unstructured":"Kramer CK, Zinman B. Sodium-Glucose Cotransporter-2 (SGLT-2) Inhibitors and the Treatment of Type 2 Diabetes. Annu Rev Med. 2019;70:323\u201334.","journal-title":"Annu Rev Med"},{"issue":"5","key":"1144_CR62","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1097\/HCO.0000000000000647","volume":"34","author":"S Verma","year":"2019","unstructured":"Verma S, Sharma A, Kanumilli N, Butler J. Predictors of heart failure development in type 2 diabetes: a practical approach. Curr Opin Cardiol. 2019;34(5):578\u201383.","journal-title":"Curr Opin Cardiol"},{"key":"1144_CR63","doi-asserted-by":"crossref","unstructured":"Kosiborod M, Cavender MA, Fu AZ, Wilding JP, Khunti K, Holl RW, Norhammar A, Birkeland KI, J\u00f8rgensen MK, Thuresson M, Arya N, Bodeg\u00e5rd J, Hammar N, Fenici P, CVD-REAL Investigators and Study Group. Lower risk of heart failure and death in patients initiated on sodium-glucose cotransporter-2 inhibitors versus other glucose-lowering drugs: the CVD-REAL study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors). Circulation. 2017;136(3):249\u201359.","DOI":"10.1161\/CIRCULATIONAHA.117.029190"},{"issue":"1","key":"1144_CR64","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12933-019-0857-6","volume":"18","author":"MB Bizino","year":"2019","unstructured":"Bizino MB, Jazet IM, Westenberg JJM, Eyk HJV, Paiman EHM, Smit JWA, Lamb HJ. Effect of liraglutide on cardiac function in patients with type 2 diabetes mellitus: randomized placebo-controlled trial. Cardiovasc Diabetol. 2019;18(1):55.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"1144_CR65","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s12933-019-0966-2","volume":"18","author":"A Shiraki","year":"2019","unstructured":"Shiraki A, Oyama JI, Nishikido T, Node K. GLP-1 analog liraglutide-induced cardiac dysfunction due to energetic starvation in heart failure with non-diabetic dilated cardiomyopathy. Cardiovasc Diabetol. 2019;18(1):164.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"1144_CR66","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s12933-019-0938-6","volume":"18","author":"M Packer","year":"2019","unstructured":"Packer M. Lessons learned from the DAPA-HF trial concerning the mechanisms of benefit of SGLT2 inhibitors on heart failure events in the context of other large-scale trials nearing completion. Cardiovasc Diabetol. 2019;18(1):129.","journal-title":"Cardiovasc Diabetol"},{"key":"1144_CR67","doi-asserted-by":"crossref","unstructured":"Jollis JG, Ancukiewicz M, DeLong ER, Pryor DB, Muhlbaier LH, Mark DB. Discordance of databases designed for claims payment versus clinical information systems. Implications for outcomes research. Ann Intern Med. 1993;119(8):844\u201350.","DOI":"10.7326\/0003-4819-119-8-199310150-00011"},{"issue":"3","key":"1144_CR68","first-page":"157","volume":"104","author":"CC Lin","year":"2005","unstructured":"Lin CC, Lai MS, Syu CY, Chang SC, Tseng FY. Accuracy of diabetes diagnosis in health insurance claims data in Taiwan. J Formos Med Assoc. 2005;104(3):157\u201363.","journal-title":"J Formos Med Assoc"},{"key":"1144_CR69","unstructured":"Gordis L. More on causal inference: bias, confounding, and interaction. In: Epidemilogy. 2nded. Philadelphia: WB Saunders, 2000. p. 204\u201317."}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-020-01144-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-020-01144-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-020-01144-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,13]],"date-time":"2021-10-13T19:57:11Z","timestamp":1634155031000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-020-01144-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,14]]},"references-count":69,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1144"],"URL":"https:\/\/doi.org\/10.1186\/s12933-020-01144-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-23178\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-23178\/v1","asserted-by":"object"}]},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,14]]},"assertion":[{"value":"15 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Institutional Review Board of National Cheng Kung University Hospital (A-EX-104-008) with no informed consent required.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that there is no duality of interest associated with this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"177"}}